&beta;2-adrenoceptor in obstructive airway diseases: Agonism, antagonism or both?

doi:10.5320/wjr.v5.i3.199

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10674)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

583

WORD

338

HTML

7273

Figures (1-3)

368

Sum=8562

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

923

Download

1189

Sum=2112

Nov 28, 2015 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Respirology

ISSN

2218-6255

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Respirol. Nov 28, 2015; 5(3): 199-206
Published online Nov 28, 2015. doi: 10.5320/wjr.v5.i3.199

Full Size Figure Download Figure

Figure 2 Potential therapeutic benefits by chronic β-blocker usage in obstructive airway diseases observed in animal and clinical studies^{[12,40,46,47,64,65]}. AR: Adrenoceptors; TNF: Tumor necrosis factor; IL: Interlukin.

Citation: Tan DW, Wong JL, Tie ST, Abisheganaden JA, Lim AY, Wong WF. β₂-adrenoceptor in obstructive airway diseases: Agonism, antagonism or both? World J Respirol 2015; 5(3): 199-206
URL: https://www.wjgnet.com/2218-6255/full/v5/i3/199.htm
DOI: https://dx.doi.org/10.5320/wjr.v5.i3.199